Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 23 studies | 42% ± 23% | |
astrocyte | 15 studies | 41% ± 19% | |
oligodendrocyte precursor cell | 13 studies | 47% ± 20% | |
smooth muscle cell | 12 studies | 31% ± 15% | |
fibroblast | 11 studies | 28% ± 14% | |
adipocyte | 8 studies | 27% ± 6% | |
endothelial cell | 7 studies | 39% ± 16% | |
ciliated cell | 6 studies | 33% ± 15% | |
club cell | 6 studies | 28% ± 13% | |
Mueller cell | 5 studies | 43% ± 22% | |
type I pneumocyte | 5 studies | 29% ± 5% | |
epithelial cell | 4 studies | 28% ± 10% | |
retinal cone cell | 4 studies | 34% ± 16% | |
cardiac muscle cell | 4 studies | 19% ± 2% | |
retinal rod cell | 4 studies | 65% ± 13% | |
GABAergic neuron | 3 studies | 35% ± 9% | |
microglial cell | 3 studies | 40% ± 18% | |
hepatocyte | 3 studies | 49% ± 18% | |
retinal pigment epithelial cell | 3 studies | 28% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 4 studies | 47% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 883.00 | 653 / 653 | 97% | 13.44 | 588 / 605 |
kidney | 100% | 578.60 | 89 / 89 | 97% | 18.78 | 870 / 901 |
stomach | 100% | 685.82 | 359 / 359 | 94% | 8.12 | 268 / 286 |
lung | 100% | 1116.91 | 578 / 578 | 92% | 8.08 | 1064 / 1155 |
intestine | 99% | 599.66 | 960 / 966 | 92% | 6.43 | 487 / 527 |
skin | 99% | 609.98 | 1791 / 1809 | 91% | 12.97 | 431 / 472 |
esophagus | 96% | 331.64 | 1394 / 1445 | 90% | 9.95 | 165 / 183 |
brain | 83% | 265.16 | 2197 / 2642 | 99% | 10.97 | 697 / 705 |
breast | 100% | 847.46 | 459 / 459 | 81% | 4.57 | 902 / 1118 |
liver | 100% | 564.35 | 226 / 226 | 74% | 3.74 | 299 / 406 |
prostate | 100% | 452.92 | 244 / 245 | 74% | 3.01 | 370 / 502 |
bladder | 90% | 445.90 | 19 / 21 | 82% | 4.72 | 411 / 504 |
uterus | 100% | 885.41 | 170 / 170 | 64% | 4.72 | 296 / 459 |
adrenal gland | 97% | 400.77 | 251 / 258 | 63% | 3.37 | 144 / 230 |
ovary | 99% | 425.98 | 178 / 180 | 57% | 2.52 | 246 / 430 |
pancreas | 36% | 71.22 | 119 / 328 | 95% | 8.10 | 169 / 178 |
adipose | 100% | 1100.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 547.37 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.87 | 1 / 1 |
muscle | 99% | 500.37 | 795 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 636.06 | 1315 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 434.79 | 827 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 6.32 | 69 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2.16 | 17 / 29 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.86 | 23 / 45 |
peripheral blood | 16% | 41.37 | 144 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0003085 | Biological process | negative regulation of systemic arterial blood pressure |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_1904694 | Biological process | negative regulation of vascular associated smooth muscle contraction |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005575 | Cellular component | cellular_component |
GO_0005737 | Cellular component | cytoplasm |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP42 |
Protein name | Rho GTPase-activating protein 42 (Rho GTPase-activating protein 10-like) (Rho-type GTPase-activating protein 42) ARHGAP42 Rho GTPase activating protein 42 Rho GTPase activating protein 42 (Transmembrane protein 133) Alternative protein ARHGAP42 |
Synonyms | hCG_1729382 TMEM133 GRAF3 |
Description | FUNCTION: May influence blood pressure by functioning as a GTPase-activating protein for RHOA in vascular smooth muscle. . |
Accessions | A0A499FIA2 L8E964 ENST00000298815.13 A6NI28 H0YDU1 H0YEJ7 ENST00000531183.1 E9PJK4 A0A2X0SYU7 ENST00000303130.4 ENST00000529535.1 ENST00000524892.7 |